Search Advanced Search
Products > Target > CapitalBio Technology Co, Ltd. | Similar Products
Your search for "

Target

" found 7 Products from CapitalBio Technology Co, Ltd., China

(1-7 out of 7)

Individualized Medication Guidance for Prostate Cancer

Individualized Medication Guidance for Prostate Cancer
This test detects 346 genes, including HRR pathway genes. The content involves targeted therapy, immunotherapy, chemotherapy and hereditary risk assessment, and provides comprehensive medication ...

Individualized Medication Guidance for Gynecologic Cancer

Individualized Medication Guidance for Gynecologic Cancer
targeted therapy, immunotherapy, chemotherapy and hereditary risk assessment, and provides comprehensive medication reference for gynecologic cancer patients.Applicable Population of Individualized ...

Individualized Medication Guidance for Gastrointestinal Cancer

Individualized Medication Guidance for Gastrointestinal Cancer
This test detects 84 genes related to gastrointestinal cancer, provides information on targeted drug, chemotherapy, and hereditary risk assessment. Features of Individualized Medication Guidance for ...

Individualized Medication Guidance for Cancer (800 Genes)

Individualized Medication Guidance for Cancer (800 Genes)
This test detects 800 genes related to targeted therapy, chemotherapy and endocrine drug, hereditary tumor, immunotherapy -related information (MSI and TMB), tumor core signaling pathway and tumor ...

Individualized Medication Guidance for Cancer (118 Genes)

Individualized Medication Guidance for Cancer (118 Genes)
This cancer genetic test detects 136 genes, including 110 targeted drug-related genes and 27 chemotherapy drug-related genes, provides the correlation between gene mutations and targeted drugs and ...

Individualized Medication Guidance for Breast Cancer

Individualized Medication Guidance for Breast Cancer
This test detects 348 genes, including HRR pathway genes. The content involves targeted breast cancer therapy, immunotherapy, chemotherapy and hereditary risk assessment, and provides comprehensive ...

Clinical WES

Clinical WES
target region capture and the NGS technology to detect all exonic regions and more than 1,000 pathogenic intron regions of nearly 4,000 genes that are clearly associated with genetic diseases, ...
Page 1 of 11
Go to Page Go

Browse: Manufacturer Directory Premium Suppliers Site Map

About EC21 Contact Us Terms & Conditions Report Item Online Trading Risks Product Listing Policy

Copyright (c)1997-2026 EC21 Inc. All Rights Reserved. EC21 in KoreanChinese

Business Registry Number: 120-86-03931 | Mall order sales Registration Number: 강남-5838

Inquiry Basket ()